When was GeniPhys founded?

GeniPhys was founded in 2014 and raised its 1st funding round 1 year after it was founded.

Where is GeniPhys located?

GeniPhys is headquartered in Zionsville, United States.

How many employees does GeniPhys have?

As of Jul 01, 2024, the latest employee count at GeniPhys is 4.

Is GeniPhys a funded company?

GeniPhys is a funded company, having raised a total of $13.5M across 7 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on May 19, 2015.

When was the latest funding round of GeniPhys?

GeniPhys' latest funding was a $***** Series A round on Jan 29, 2026, with participation from 0 investor.

Where does GeniPhys rank among its competitors?

GeniPhys ranks 5th amongst 66 active competitors, of which 25 are funded. It stands 7th in terms of total funding among its competitors.

Who are the top competitors of GeniPhys?

GeniPhys' top competitors include Organogenesis, Collplant and Jellatech. Among them, GeniPhys secured the most recent funding round in January, 2026.

GeniPhys - 2026 Company Profile, Team, Funding & Competitors

GeniPhys is a series A company based in Zionsville (United States), founded in 2014 by Sherry Harbin. It operates as a Developer of collagen polymers for tissue regeneration. GeniPhys has raised $13.5M in funding. The company has 66 active competitors, including 25 funded and 6 that have exited. Its top competitors include companies like Organogenesis, Collplant and Jellatech.

Company Details

Developer of collagen polymers for tissue regeneration. It offers Collymer a polymerizable scaffold-forming collagen that supports tissue restoration and regeneration. It is used in cartilage replacement, vascular grafts, and heart valve replacement, and others.

Website: www.geniphys.com/
Email ID: *****@geniphys.com
Phone Number: +1 **********

Key Metrics

Founded Year

2014

Location

Zionsville, United States

Stage

Series A

Total Funding

$13.5M in 7 rounds

Latest Funding Round

Series A, Jan 29, 2026, $*****

Investors

National Science Foundation & 3 more

Ranked

5^th among 66 active competitors

Employee Count

4 as on Jul 01, 2024

Similar Companies

Organogenesis & 79 more

View GeniPhys' full profile

GeniPhys is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Geniphys, Inc. CIN: 471069451 , United States, Active	Nov 28, 2022	-	-	-

GeniPhys has raised a total funding of $13.5M over 7 rounds. Its first funding round was on May 19, 2015. GeniPhys has 4 institutional investors.

Here is the list of recent funding rounds of GeniPhys:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 29, 2026	8014608	Series A	4558377	3652892	7298671	8877010
Oct 24, 2024	1734560	Grant (prize money)	5536479	7435986	6004907	America’s Seed Fund
Mar 29, 2023	9566513	Series A	5070174	9039393	9448655	Pier 70 Ventures & 1 more

Access funding benchmarks and valuations. Sign up today!

View details of GeniPhys's funding rounds and investors

The founders of GeniPhys is Sherry Harbin.

Here are the details of GeniPhys' key team members:

Sherry Harbin: Founder of GeniPhys.
Contact Info: 1 email address
Ron Ellis: CEO of GeniPhys and founder of 1 other company.

View details of GeniPhys's Founder profiles and Board Members

GeniPhys' employee count trend

GeniPhys has 4 employees as of Jul 24. Here is GeniPhys's employee count trend over the years:

Uncover GeniPhys' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of GeniPhys include Organogenesis, Collplant and Jellatech. Here is the list of Top 10 competitors of GeniPhys, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Organogenesis 1985, Canton (United States), Public	Regenerative therapies for wound care	$30M	Eastward Capital Partners, Spring St. Group ... & 2 others	56/100
2nd	Collplant 2004, Ness Ziona (Israel), Public	Develops plant-derived collagen products for tissue repair, 3D bio-printing	$16.3M	Pontifax, Docor & 4 others	52/100
3rd	Jellatech 2020, Morrisville (United States), Seed	Provider of animal-free collagen and gelatin products for multiple industries	$5.5M	Seven Hound Ventures, Siddhi Capital & 12 others	50/100
4th	BioTissue 2001, Miami (United States), Series C	Developer of regenerative biologic therapies for eye care	$110M	EW Healthcare Partners, HHS & 2 others	46/100
5th	GeniPhys 2014, Zionsville (United States), Series A	Developer of collagen polymers for tissue regeneration	$13.5M	National Science Foundation, Elevate Ventures ... & 2 others	51/100
6th	Marizyme 2007, Woodstock (United States), Public	Developer of therapy for the treatment of chronic wounds, thrombolysis, and dental health	-	-	45/100
7th	Acera Surgical 2013, St. Louis (United States), Series A	Provider of synthetic electrospun scaffolds for regenerative medical applications	$6.32M	Missouri Technology, MBX Capital & 1 others	45/100
8th	Sofregen 2014, Medford (United States), Series B	Silk-derived biomaterials for regenerative, reconstructive and aesthetic surgery	$19.4M	Polaris Partners, Anzu Partners	42/100
9th	Reapplix 2008, Rudersdal (Denmark), Series B	Developer of patch system for wound healing	$52.4M	Novo Holdings, Seed Capital & 8 others	42/100
10th	BioLab Sciences 2018, Scottsdale (United States), Unfunded	Developer of regenerative therapies for wound healing	-	-	39/100